Literature DB >> 1327959

HAP1 positive control mutants specific for one of two binding sites.

B Turcotte1, L Guarente.   

Abstract

The expression of the yeast CYC1 and CYC7 genes is controlled by the HAP1 activator. A GAL4-like zinc finger (residues 1-148) specifies binding to the dissimilar sites UAS1 (of CYC1) and CYC7, and an acidic domain (residues 1307-1483) is essential for activation of transcription. To analyze how HAP1 binds to UAS1 and CYC7, we performed saturation mutagenesis of the DNA-binding domain and recovered mutants with altered activity. Class 1 mutants had a reduced activity at both UAS1 and CYC7, and class 2 mutants selectively eliminated activity at CYC7. Surprisingly, several mutants of both classes exhibited wild-type DNA binding, indicating that they were specifically defective in activation. These positive control (PC) mutants alter residues that bracket the zinc finger. We explain these mutants in a model involving cofactor proteins that bind UAS1 and CYC7 along with HAP1. The existence of PC mutants that only affect activity at CYC7 raises the possibility that different cofactors may exist for UAS1 and CYC7.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1327959     DOI: 10.1101/gad.6.10.2001

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  24 in total

1.  Structure of HAP1-PC7 bound to DNA: implications for DNA recognition and allosteric effects of DNA-binding on transcriptional activation.

Authors:  A K Lukens; D A King; R Marmorstein
Journal:  Nucleic Acids Res       Date:  2000-10-15       Impact factor: 16.971

2.  The Hsp70-Ydj1 molecular chaperone represses the activity of the heme activator protein Hap1 in the absence of heme.

Authors:  T Hon; H C Lee; A Hach; J L Johnson; E A Craig; H Erdjument-Bromage; P Tempst; L Zhang
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

3.  NMR analysis of CYP1(HAP1) DNA binding domain-CYC1 upstream activation sequence interactions: recognition of a CGG trinucleotide and of an additional thymine 5 bp downstream by the zinc cluster and the N-terminal extremity of the protein.

Authors:  A L Vuidepot; F Bontems; M Gervais; B Guiard; E Shechter; J Y Lallemand
Journal:  Nucleic Acids Res       Date:  1997-08-01       Impact factor: 16.971

4.  Molecular mechanism governing heme signaling in yeast: a higher-order complex mediates heme regulation of the transcriptional activator HAP1.

Authors:  L Zhang; A Hach; C Wang
Journal:  Mol Cell Biol       Date:  1998-07       Impact factor: 4.272

5.  Mutations in target DNA elements of yeast HAP1 modulate its transcriptional activity without affecting DNA binding.

Authors:  N Ha; K Hellauer; B Turcotte
Journal:  Nucleic Acids Res       Date:  1996-04-15       Impact factor: 16.971

6.  Fusions with histone H3 result in highly specific alteration of gene expression.

Authors:  N Ha; K Hellauer; B Turcotte
Journal:  Nucleic Acids Res       Date:  2000-02-15       Impact factor: 16.971

7.  Fos-Jun dimerization promotes interaction of the basic region with TFIIE-34 and TFIIF.

Authors:  M L Martin; P M Lieberman; T Curran
Journal:  Mol Cell Biol       Date:  1996-05       Impact factor: 4.272

8.  The heme activator protein Hap1 represses transcription by a heme-independent mechanism in Saccharomyces cerevisiae.

Authors:  Thomas Hon; Hee Chul Lee; Zhanzhi Hu; Vishwanath R Iyer; Li Zhang
Journal:  Genetics       Date:  2005-01-16       Impact factor: 4.562

9.  Antibody-promoted dimerization bypasses the regulation of DNA binding by the heme domain of the yeast transcriptional activator HAP1.

Authors:  L Zhang; O Bermingham-McDonogh; B Turcotte; L Guarente
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

10.  Structural environment dictates the biological significance of heme-responsive motifs and the role of Hsp90 in the activation of the heme activator protein Hap1.

Authors:  Hee Chul Lee; Thomas Hon; Changgui Lan; Li Zhang
Journal:  Mol Cell Biol       Date:  2003-08       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.